ロード中...
Characterization of chronic myeloid leukemia stem cells
Though tyrosine kinase inhibitors have redefined the care of chronic myeloid leukemia (CML), these agents have not proved curative, likely due to resistance of the leukemia stem cells (LSC). While a number of potential therapeutic targets have emerged in CML, their expression in the LSC remains larg...
保存先:
主要な著者: | , , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2011
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3010878/ https://ncbi.nlm.nih.gov/pubmed/21132730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21915 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|